Mo Cheng
Impact in
- Rheumatology top 10%
- Bone Tumor Diagnosis and Treatments
Papers in
-
- Bone Tumor Diagnosis and Treatments 8
- Surgery 8
- Management of metastatic bone disease 7
- Spinal Fractures and Fixation Techniques 5
- Co-authors
- Wangjun Yan (18 shared papers)Wending Huang (15 shared papers)Weiluo Cai (15 shared papers)Jianru Xiao (3 shared papers)Wangjun Yan (3 shared papers)Wei Xu (3 shared papers)Huabin Yin (3 shared papers)Jing Wang (3 shared papers)
- Journals
- Communications Biology (1 paper)ACS Biomaterials Science & Engineering (1 paper)European Journal of Pharmacology (1 paper)International Journal of Biological Sciences (1 paper)Cell Reports Medicine (1 paper)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Mo Cheng
19 papers receiving 415 citations
Peers
Comparison fields: 5 of 47
- Rheumatology 114
- Cancer Research 42
- Biomedical Engineering 105
- Biomaterials 25
- Hepatology 13
Countries citing papers authored by Mo Cheng
This map shows the geographic impact of Mo Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mo Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mo Cheng more than expected).
Fields of papers citing papers by Mo Cheng
This network shows the impact of papers produced by Mo Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mo Cheng. The network helps show where Mo Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Mo Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 75 | |
| 2 | 2017 | 75 | |
| 3 | 2020 | 46 | |
| 4 | 2014 | 34 | |
| 5 | 2022 | 23 | |
| 6 | 2018 | 22 | |
| 7 | 2015 | 19 | |
| 8 | 2022 | 18 | |
| 9 | 2022 | 15 | |
| 10 | 2024 | 15 | |
| 11 | 2022 | 13 | |
| 12 | 2023 | 13 | |
| 13 | 2021 | 10 | |
| 14 | 2023 | 10 | |
| 15 | 2019 | 9 | |
| 16 | 2022 | 9 | |
| 17 | 2024 | 7 | |
| 18 | 2024 | 4 | |
| 19 | 2023 | 3 | |
| 20 | 2022 | 0 |
About Mo Cheng
Mo Cheng is a scholar working on Rheumatology, Surgery, Pulmonary and Respiratory Medicine, Oncology and Biomaterials, having authored 25 papers that have together received 420 indexed citations. Recurring topics across this work include Bone Tumor Diagnosis and Treatments (8 papers), Management of metastatic bone disease (7 papers), Sarcoma Diagnosis and Treatment (5 papers), Spinal Fractures and Fixation Techniques (5 papers), Nanoplatforms for cancer theranostics (3 papers), Nanoparticle-Based Drug Delivery (2 papers), Cancer Immunotherapy and Biomarkers (1 paper) and Bone health and treatments (1 paper). The work is most often cited by research in Rheumatology (114 citations), Cancer Research (42 citations), Biomedical Engineering (105 citations), Biomaterials (25 citations) and Hepatology (13 citations). Mo Cheng has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Wangjun Yan, Wending Huang, Weiluo Cai, Jianru Xiao, Wangjun Yan, Wei Xu, Huabin Yin, Jing Wang, Tong Meng and Meng Xiang Fang. Their work appears in journals such as Communications Biology, ACS Biomaterials Science & Engineering, European Journal of Pharmacology, International Journal of Biological Sciences and Cell Reports Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.